Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.
Saved in:
| Title: | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. |
|---|---|
| Authors: | Karnes JH; Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona, USA.; Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA., Rettie AE; Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA., Somogyi AA; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia., Huddart R; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Fohner AE; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA., Formea CM; Department of Pharmacy and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA., Ta Michael Lee M; Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA., Llerena A; INUBE Extremadura University Biosanitary Research Institute and Medical School, Badajoz, Spain., Whirl-Carrillo M; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Klein TE; Department of Biomedical Data Science, Stanford University, Stanford, California, USA.; Department of Medicine, Stanford University, Stanford, California, USA., Phillips EJ; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Mintzer S; Department of Neurology, Thomas Jefferson University Hospital Methodist Hospital Division of Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Caudle KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Callaghan JT; Department of Veteran Affairs and Departments of Medicine and Pharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Feb; Vol. 109 (2), pp. 302-309. Date of Electronic Publication: 2020 Sep 06. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Practice Guideline |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.2008 |
